However, only DCs loaded with sHS-treated tumor cells stimulated antigen-specific CD4<sup>+</sup> T cells and induced higher CD8<sup>+</sup> T-cell activation and proliferation. sHS-treated murine cells also exposed calreticulin, HSP70 and HSP90 and activated higher DC maturation than mHS treated cells.